Your browser doesn't support javascript.
Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020.
Chalasani, Rohan; Shinabery, Jared M; Goetz, Carrie Thomas; Chang, Chung-Chou H; Yang, Qingnan; Suda, Katie J; Gellad, Walid F.
  • Chalasani R; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Shinabery JM; Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA.
  • Goetz CT; Drug Surveillance and Misuse Prevention Office, Pennsylvania Department of Health, Harrisburg, PA, USA.
  • Chang CH; Drug Surveillance and Misuse Prevention Office, Pennsylvania Department of Health, Harrisburg, PA, USA.
  • Yang Q; Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Suda KJ; Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA.
  • Gellad WF; Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA.
J Gen Intern Med ; 36(12): 3915-3917, 2021 12.
Article in English | MEDLINE | ID: covidwho-1351346

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11606-021-07083-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11606-021-07083-y